Skip to main content
LobbyMap

Summit Pharma Resources

Technology & Internet · Lobbying Client

C
Influence Score
41/100
Moderate Influence
$2.3M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door

Summit Pharma Resources reported $2.3 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Computer Industry, Telecommunications, Copyright/Patent/Trademark. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Interior
Securities & Exchange Commission
Federal Aviation Administration
Dept of Energy
US Senate
US House of Representatives

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarK&L Gates LLP
TECGOV
1$108K
2020 Apr-JunBGR Group LLP
CPITECGOV+1
1$87K
2020 Jul-SepAkin Gump LLP
CPT
1$115K
2020 Oct-DecCassidy & Associates LLP
CPITEC
1$131K
2021 Jan-MarBGR Group LLP
TECCPI
1$89K
2021 Apr-JunSquire Patton Boggs LLP
TEC
1$125K
2021 Jul-SepBGR Group LLP
CPTCPI
1$118K
2021 Oct-DecK&L Gates LLP
CPICPTGOV+1
1$97K

Summit Pharma Resources Lobbying FAQ

Summit Pharma Resources has spent $2.3M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Summit Pharma Resources lobbies on 4 policy issues, including Computer Industry, Telecommunications, Copyright/Patent/Trademark, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Summit Pharma Resources has an Influence Score of 41/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Summit Pharma Resources employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Summit Pharma Resources has contacted 6 government entities as part of their lobbying activities, including Dept of Interior, Securities & Exchange Commission, Federal Aviation Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.